Accelerating access to hepatitis C diagnostics and treatment PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Accelerating access to hepatitis C diagnostics and treatment PDF full book. Access full book title Accelerating access to hepatitis C diagnostics and treatment by . Download full books in PDF and EPUB format.
Author:
Publisher: World Health Organization
ISBN: 9240019006
Category : Medical
Languages : en
Pages : 76
Get Book Here
Book Description
WHO approved more hepatitis direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) by 2020 which helped low- and middle-income countries increase the number of registered treatments, reduce prices of a full treatment under US$100 – update is as low as $60 for three months, and strive towards hepatitis C elimination. For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners. Globally, at the end of 2017, only 5 million – or 7% – of the 71 (62–79) million people chronically infected with HCV had cumulatively received treatment with DAAs. As countries continue to tackle the disease burden and service disruptions caused by the COVID-19 pandemic, it is critical to ensure that the recent momentum and gains in the response to hepatitis C are not lost. Against this backdrop, this report is a strong reminder to continue to invest in building resilient and sustainable health systems that are focused on universal health coverage.
Author:
Publisher: World Health Organization
ISBN: 9240019006
Category : Medical
Languages : en
Pages : 76
Get Book Here
Book Description
WHO approved more hepatitis direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) by 2020 which helped low- and middle-income countries increase the number of registered treatments, reduce prices of a full treatment under US$100 – update is as low as $60 for three months, and strive towards hepatitis C elimination. For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners. Globally, at the end of 2017, only 5 million – or 7% – of the 71 (62–79) million people chronically infected with HCV had cumulatively received treatment with DAAs. As countries continue to tackle the disease burden and service disruptions caused by the COVID-19 pandemic, it is critical to ensure that the recent momentum and gains in the response to hepatitis C are not lost. Against this backdrop, this report is a strong reminder to continue to invest in building resilient and sustainable health systems that are focused on universal health coverage.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240052739
Category : Medical
Languages : en
Pages : 155
Get Book Here
Book Description
Author: World Health Organization
Publisher: World Health Organization
ISBN: 924009167X
Category : Medical
Languages : en
Pages : 244
Get Book Here
Book Description
This is the first consolidated WHO report on viral hepatitis epidemiology, service coverage and product access, with improved data for action. This report presents the latest estimates on the disease burden and the coverage of essential viral hepatitis services from 187 countries across the world. The report also updates progress made since 2019 in improving access to health products for both hepatitis B and C in low- and middle-income countries, with information from 38 countries that together comprise nearly 80% of global viral hepatitis infections and deaths. The report provides a regional perspective, analysing the barriers and opportunities for countries in each of the 6 WHO regions to expand access to health products for viral hepatitis. It presents actions for countries and stakeholders to accelerate the scaling up of effective viral hepatitis interventions within a public health approach.
Author: Wai-Kay Seto
Publisher: Elsevier
ISBN: 0323913105
Category : Science
Languages : en
Pages : 678
Get Book Here
Book Description
The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology. - Provides comprehensive coverage of the different types of hepatitis - Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care - Discusses future development specific to different types of hepatitis
Author: Victor Roy
Publisher: Univ of California Press
ISBN: 0520388720
Category : Medical
Languages : en
Pages : 216
Get Book Here
Book Description
A free open access ebook is available upon publication. Learn more at www.luminosoa.org. Capitalizing a Cure takes readers into the struggle over a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When curative treatments for hepatitis C launched in 2013, sticker shock over their prices intensified the global debate over access to new medicines. Weaving historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued. Roy’s account moves between public and private labs, Wall Street and corporate board rooms, and public health meetings and health centers to trace the ways in which curative medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to determine who heals and who suffers and points to the necessary work of building more equitable futures.
Author:
Publisher: World Health Organization
ISBN: 9240028390
Category : Medical
Languages : en
Pages : 96
Get Book Here
Book Description
In 2016, the World Health Assembly adopted the Global Health Sector Strategy (GHSS) on viral hepatitis. The GHSS called for elimination of viral hepatitis B and C infection as a public health problem (defined as a 90% reduction in incidence [95% for HBV and 80% for HCV] and 65% reduction in mortality by 2030, compared with the 2015 baseline). A broad range of countries have now developed national viral hepatitis plans, and several countries also requested guidance from the World Health Organization (WHO) on the establishment of global criteria for measuring elimination of viral hepatitis and a standardized process for validation of elimination. WHO has developed this interim guidance for countries and other stakeholders seeking validation of elimination of viral hepatitis as a public health problem, with a specific focus on hepatitis B virus (HBV) and hepatitis C virus (HCV). It provides a global framework for the processes and standards for validation of elimination, and overall proposes the use of absolute impact targets to validate elimination at the national level (instead of, although equivalent to, the relative reduction targets originally defined in the 2016 GHSS) in combination with a set of programmatic targets.
Author:
Publisher: World Health Organization
ISBN: 9240027076
Category : Medical
Languages : en
Pages : 112
Get Book Here
Book Description
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240078630
Category : Medical
Languages : en
Pages : 112
Get Book Here
Book Description
Author: World Health Organization
Publisher: World Health Organization
ISBN: 924009492X
Category : Medical
Languages : en
Pages : 69
Get Book Here
Book Description
This report is the first of a series of biennial progress reports on the implementation of the Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. It draws attention to areas of progress and gaps in preparation for the mid-term review of the strategies in 2026.
Author: Kathryn H. Jacobsen
Publisher: Jones & Bartlett Learning
ISBN: 1284282082
Category : Medical
Languages : en
Pages : 624
Get Book Here
Book Description
Introduction to Global Health is a comprehensive look at today’s most critical global health concerns and the actions that people around the world are taking to solve public health problems and to promote health and wellbeing. The Fourth Edition of Introduction to Global Health maintains the clarity and ease of use of the prior edition, while featuring a greater emphasis on the specific interventions that are being implemented to promote longer, healthier lives worldwide and prevent disease, disability, and early death in countries of all income levels. Every chapter balances material about pandemics, climate change, and other emerging threats to global public health with evidence of how global health interventions are enabling progress toward achieving health equity.
